A detailed history of Pfg Investments, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pfg Investments, LLC holds 2,009 shares of VRTX stock, worth $976,353. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,009
Previous 1,800 11.61%
Holding current value
$976,353
Previous $732 Million 14.66%
% of portfolio
0.05%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$407.69 - $446.08 $85,207 - $93,230
209 Added 11.61%
2,009 $840 Million
Q4 2023

Jan 17, 2024

BUY
$343.0 - $410.68 $344,372 - $412,322
1,004 Added 126.13%
1,800 $732 Million
Q3 2023

Nov 06, 2023

SELL
$338.18 - $362.46 $2,367 - $2,537
-7 Reduced 0.87%
796 $277 Million
Q2 2023

Aug 03, 2023

BUY
$314.42 - $351.91 $252,479 - $282,583
803 New
803 $283 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $125B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.